{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:49:57Z","timestamp":1792028997322,"version":"4.4.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T00:00:00Z","timestamp":1702684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.redox.2023.103004","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:49:45Z","timestamp":1702946985000},"page":"103004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Myeloid ACE2 protects against septic hypotension and vascular dysfunction through Ang-(1\u20137)-Mas-mediated macrophage polarization"],"prefix":"10.1016","volume":"69","author":[{"given":"Jia-Xin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10141","key":"10.1016\/j.redox.2023.103004_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","article-title":"Sepsis and septic shock","volume":"392","author":"Cecconi","year":"2018","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.redox.2023.103004_bib2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/cc13733","article-title":"Soluble adhesion molecules as markers for sepsis and the potential pathophysiological discrepancy in neonates","volume":"18","author":"Zonneveld","year":"2014","journal-title":"children and adults, Critical care (London, England)"},{"key":"10.1016\/j.redox.2023.103004_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101638","article-title":"Targeting NOX4 alleviates sepsis-induced acute lung injury via attenuation of redox-sensitive activation of CaMKII\/ERK1\/2\/MLCK and endothelial cell barrier dysfunction","volume":"36","author":"Jiang","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2023.103004_bib4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.redox.2016.09.016","article-title":"Impaired vascular function in sepsis-surviving rats mediated by oxidative stress and Rho-Kinase pathway","volume":"10","author":"de Souza","year":"2016","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.redox.2023.103004_bib5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1540\/jsmr.43.117","article-title":"Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction","volume":"43","author":"Matsuda","year":"2007","journal-title":"Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi"},{"issue":"2","key":"10.1016\/j.redox.2023.103004_bib6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41569-019-0244-8","article-title":"Counter-regulatory renin-angiotensin system in cardiovascular disease","volume":"17","author":"Paz Ocaranza","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.redox.2023.103004_bib7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.biopha.2017.07.091","article-title":"Renin-angiotensin-aldosterone (RAAS): the ubiquitous system for homeostasis and pathologies","volume":"94","author":"Patel","year":"2017","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"1","key":"10.1016\/j.redox.2023.103004_bib8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/cei.12612","article-title":"Human monocyte subsets exhibit divergent angiotensin I-converting activity","volume":"181","author":"Rutkowska-Zapa\u0142a","year":"2015","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.redox.2023.103004_bib9","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00408-020-00408-4","article-title":"ACE2: the major cell entry receptor for SARS-CoV-2","volume":"198","author":"Scialo","year":"2020","journal-title":"Lung"},{"key":"10.1016\/j.redox.2023.103004_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2021.170612","article-title":"Angiotensin-(1-7) protects against sepsis-associated left ventricular dysfunction induced by lipopolysaccharide","volume":"144","author":"Xu","year":"2021","journal-title":"Peptides"},{"key":"10.1016\/j.redox.2023.103004_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108562","article-title":"The angiotensin-converting enzyme 2\/angiotensin (1-7)\/mas axis protects against pyroptosis in LPS-induced lung injury by inhibiting NLRP3 activation","volume":"693","author":"Huang","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.redox.2023.103004_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2019.104350","article-title":"ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway","volume":"113","author":"Ye","year":"2020","journal-title":"Exp. Mol. Pathol."},{"issue":"7","key":"10.1016\/j.redox.2023.103004_bib13","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.34067\/KID.0001562021","article-title":"Expression of ACE2 in the intact and acutely injured kidney","volume":"2","author":"Nath","year":"2021","journal-title":"Kidney360"},{"issue":"10","key":"10.1016\/j.redox.2023.103004_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13480","article-title":"Activation of angiotensin-converting enzyme 2\/angiotensin (1-7)\/mas receptor axis triggers autophagy and suppresses microglia proinflammatory polarization via forkhead box class O1 signaling","volume":"20","author":"Dang","year":"2021","journal-title":"Aging Cell"},{"issue":"6","key":"10.1016\/j.redox.2023.103004_bib15","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1167\/iovs.14-13883","article-title":"Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice","volume":"55","author":"Qiu","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.redox.2023.103004_bib16","first-page":"588","article-title":"[Establishment of Ace2 knockout mouse model with CRISPR\/Cas9 gene targeting technology], Sheng li xue bao","volume":"71","author":"Liu","year":"2019","journal-title":"Acta Physiol. Sin."},{"issue":"3","key":"10.1016\/j.redox.2023.103004_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032112","article-title":"Deficiency of S100A9 alleviates sepsis-induced acute liver injury through regulating AKT-AMPK-dependent mitochondrial energy metabolism","volume":"24","author":"Zhang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2023.103004_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109716","article-title":"S100a8\/a9 contributes to sepsis-induced cardiomyopathy by activating ERK1\/2-Drp1-mediated mitochondrial fission and respiratory dysfunction","volume":"115","author":"Wu","year":"2023","journal-title":"Int. Immunopharm."},{"issue":"9","key":"10.1016\/j.redox.2023.103004_bib19","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.immuni.2021.08.005","article-title":"Sepsis expands a CD39(+) plasmablast population that promotes immunosuppression via adenosine-mediated inhibition of macrophage antimicrobial activity","volume":"54","author":"Nascimento","year":"2021","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.redox.2023.103004_bib20","first-page":"378","article-title":"Blockade of intercellular adhesion molecule-1 prevents angiotensin II-induced hypertension and vascular dysfunction, Laboratory investigation","volume":"100","author":"Lang","year":"2020","journal-title":"a journal of technical methods and pathology"},{"issue":"18","key":"10.1016\/j.redox.2023.103004_bib21","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1161\/CIRCULATIONAHA.115.020754","article-title":"Genetic and pharmacologic inhibition of the chemokine receptor CXCR2 prevents experimental hypertension and vascular dysfunction","volume":"134","author":"Wang","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.redox.2023.103004_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.825459","article-title":"Blocking VCAM-1 prevents angiotensin II-induced hypertension and vascular remodeling in mice","volume":"13","author":"Yin","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"20","key":"10.1016\/j.redox.2023.103004_bib23","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1093\/eurheartj\/ehy085","article-title":"CXCL1-CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration","volume":"39","author":"Wang","year":"2018","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.redox.2023.103004_bib24","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nm1103","article-title":"Selective inactivation or reconstitution of adenosine A2A receptors in bone marrow cells reveals their significant contribution to the development of ischemic brain injury","volume":"10","author":"Yu","year":"2004","journal-title":"Nature medicine"},{"issue":"1","key":"10.1016\/j.redox.2023.103004_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/HYPERTENSIONAHA.122.20328","article-title":"Integrin CD11b contributes to hypertension and vascular dysfunction through mediating macrophage adhesion and migration","volume":"80","author":"Lin","year":"2023","journal-title":"Hypertension (Dallas, Tex. : 1979)"},{"key":"10.1016\/j.redox.2023.103004_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118177","article-title":"Possible contribution of the neprilysin\/ACE pathway to sepsis in mice","volume":"258","author":"Ugan","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.redox.2023.103004_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1124\/jpet.107.130609","article-title":"Treatment of sepsis-induced acquired protein C deficiency reverses Angiotensin-converting enzyme-2 inhibition and decreases pulmonary inflammatory response","volume":"325","author":"Richardson","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.redox.2023.103004_bib28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejim.2020.04.037","article-title":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection","volume":"76","author":"Verdecchia","year":"2020","journal-title":"Eur. J. Intern. Med."},{"issue":"3","key":"10.1016\/j.redox.2023.103004_bib29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.burns.2016.09.023","article-title":"Oxidative stress in sepsis: pathophysiological implications justifying antioxidant co-therapy, Burns","volume":"43","author":"Prauchner","year":"2017","journal-title":"journal of the International Society for Burn Injuries"},{"issue":"2","key":"10.1016\/j.redox.2023.103004_bib30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/SHK.0b013e31821e4e04","article-title":"Endothelial cell activation in emergency department patients with sepsis-related and non-sepsis-related hypotension","volume":"36","author":"Schuetz","year":"2011","journal-title":"Shock"},{"key":"10.1016\/j.redox.2023.103004_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101875","article-title":"Redox-related biomarkers in human cardiovascular disease - classical footprints and beyond","volume":"42","author":"Daiber","year":"2021","journal-title":"Redox Biol."},{"issue":"5","key":"10.1016\/j.redox.2023.103004_bib32","doi-asserted-by":"crossref","first-page":"520","DOI":"10.7150\/ijbs.8879","article-title":"Macrophage polarization in inflammatory diseases","volume":"10","author":"Liu","year":"2014","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.redox.2023.103004_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107791","article-title":"The roles of macrophage polarization in the host immune response to sepsis","volume":"96","author":"Chen","year":"2021","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.redox.2023.103004_bib34","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2147\/JIR.S307801","article-title":"The ACE2-ang-(1-7)-mas Axis modulates M1\/M2 macrophage polarization to relieve CLP-induced inflammation via TLR4-mediated NF-\u043ab and MAPK pathways","volume":"14","author":"Pan","year":"2021","journal-title":"J. Inflamm. Res."},{"issue":"14","key":"10.1016\/j.redox.2023.103004_bib35","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1161\/01.CIR.0000094733.61689.D4","article-title":"Angiotensin-(1-7) formation in the intact human heart: in vivo dependence on angiotensin II as substrate","volume":"108","author":"Zisman","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.redox.2023.103004_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101295","article-title":"Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: role of renin-angiotensin system","volume":"26","author":"Cui","year":"2019","journal-title":"Redox Biol."},{"issue":"5","key":"10.1016\/j.redox.2023.103004_bib37","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.redox.2023.103004_bib38","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/ATVBAHA.120.315229","article-title":"ACE2 (Angiotensin-Converting enzyme 2) and TMPRSS2 (transmembrane serine protease 2) expression and localization of SARS-CoV-2 infection in the human heart","volume":"41","author":"Sakamoto","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.redox.2023.103004_bib39","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41392-022-01054-3","article-title":"Cardiomyocyte-specific knockout of ADAM17 ameliorates left ventricular remodeling and function in diabetic cardiomyopathy of mice","volume":"7","author":"Xue","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.redox.2023.103004_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2337\/db15-0399","article-title":"ACE2 deficiency worsens epicardial adipose tissue inflammation and cardiac dysfunction in response to diet-induced obesity","volume":"65","author":"Patel","year":"2016","journal-title":"Diabetes"},{"issue":"34","key":"10.1016\/j.redox.2023.103004_bib41","doi-asserted-by":"crossref","first-page":"30113","DOI":"10.1074\/jbc.M505111200","article-title":"Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)","volume":"280","author":"Lambert","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.redox.2023.103004_bib42","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1042\/CS20200480","article-title":"ACE2\/Ang-(1-7)\/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease","volume":"135","author":"Kuriakose","year":"2021","journal-title":"Clinical science (London, England : 1979)"},{"issue":"8","key":"10.1016\/j.redox.2023.103004_bib43","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.cell.2021.02.053","article-title":"Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system","volume":"184","author":"Yeung","year":"2021","journal-title":"Cell"},{"issue":"10256","key":"10.1016\/j.redox.2023.103004_bib44","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0140-6736(20)31964-4","article-title":"Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis","volume":"396","author":"Narula","year":"2020","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.redox.2023.103004_bib45","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/HYPERTENSIONAHA.121.18295","article-title":"Dysregulation of ACE (Angiotensin-Converting enzyme)-2 and renin-angiotensin peptides in SARS-CoV-2 mediated mortality and end-organ injuries","volume":"79","author":"Wang","year":"2022","journal-title":"Hypertension (Dallas, Tex. : 1979)"},{"issue":"7","key":"10.1016\/j.redox.2023.103004_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ph14070695","article-title":"Soluble angiotensin converting enzyme 2 (ACE2) is upregulated and soluble endothelial nitric oxide synthase (eNOS) is downregulated in COVID-19-induced acute respiratory distress syndrome (ARDS)","volume":"14","author":"Vassiliou","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10.1016\/j.redox.2023.103004_bib47","doi-asserted-by":"crossref","first-page":"H1084","DOI":"10.1152\/ajpheart.00217.2020","article-title":"COVID-19, ACE2, and the cardiovascular consequences","volume":"318","author":"South","year":"2020","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"8","key":"10.1016\/j.redox.2023.103004_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084177","article-title":"COVID-19: direct and indirect mechanisms of statins","volume":"22","author":"Pawlos","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.redox.2023.103004_bib49","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cmet.2020.06.015","article-title":"In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19","volume":"32","author":"Zhang","year":"2020","journal-title":"Cell Metabol."},{"issue":"1","key":"10.1016\/j.redox.2023.103004_bib50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.21037\/atm-22-6016","article-title":"Recombinant human angiotensin-converting enzyme 2 plays a protective role in mice with sepsis-induced cardiac dysfunction through multiple signaling pathways dependent on converting angiotensin II to angiotensin 1-7","volume":"11","author":"Wu","year":"2023","journal-title":"Ann. Transl. Med."},{"issue":"2","key":"10.1016\/j.redox.2023.103004_bib51","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/MCO.0b013e3283428df1","article-title":"Burns: where are we standing with propranolol, oxandrolone, recombinant human growth hormone, and the new incretin analogs?","volume":"14","author":"Gauglitz","year":"2011","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"1","key":"10.1016\/j.redox.2023.103004_bib52","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/imr.12499","article-title":"The immune system's role in sepsis progression, resolution, and long-term outcome","volume":"274","author":"Delano","year":"2016","journal-title":"Immunol. Rev."},{"issue":"9","key":"10.1016\/j.redox.2023.103004_bib53","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1002\/jcp.26429","article-title":"Macrophage plasticity, polarization, and function in health and disease","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.redox.2023.103004_bib54","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1097\/TA.0b013e318256e000","article-title":"Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care","volume":"72","author":"Gentile","year":"2012","journal-title":"J. Trauma Acute Care Surg."},{"issue":"5","key":"10.1016\/j.redox.2023.103004_bib55","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1097\/CCM.0b013e3181d8cc1d","article-title":"Long-term mortality and quality of life in sepsis: a systematic review","volume":"38","author":"Winters","year":"2010","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.redox.2023.103004_bib56","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13578-023-00967-y","article-title":"Ang-(1-7)\/MasR axis promotes functional recovery after spinal cord injury by regulating microglia\/macrophage polarization","volume":"13","author":"Gu","year":"2023","journal-title":"Cell Biosci."},{"key":"10.1016\/j.redox.2023.103004_bib57","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12974-016-0489-7","article-title":"Angiotensin-converting enzyme 2 activator diminazene aceturate prevents lipopolysaccharide-induced inflammation by inhibiting MAPK and NF-\u03baB pathways in human retinal pigment epithelium","volume":"13","author":"Tao","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"8","key":"10.1016\/j.redox.2023.103004_bib58","doi-asserted-by":"crossref","first-page":"10505","DOI":"10.1096\/fj.202001020R","article-title":"The ACE2-deficient mouse: a model for a cytokine storm-driven inflammation","volume":"34","author":"Wang","year":"2020","journal-title":"Faseb. J. : official publication of the Federation of American Societies for Experimental Biology"},{"issue":"11","key":"10.1016\/j.redox.2023.103004_bib59","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2174\/1389450117666160727142401","article-title":"The anti-inflammatory potential of ACE2\/angiotensin-(1-7)\/mas receptor Axis: evidence from basic and clinical research","volume":"18","author":"Rodrigues Prestes","year":"2017","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.redox.2023.103004_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.728896","article-title":"SARS-CoV-2 coronavirus spike protein-induced apoptosis, inflammatory, and oxidative stress responses in THP-1-like-macrophages: potential role of angiotensin-converting enzyme inhibitor (perindopril)","volume":"12","author":"Barhoumi","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.redox.2023.103004_bib61","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1161\/ATVBAHA.110.221614","article-title":"Angiotensin-converting enzyme 2 deficiency in whole body or bone marrow-derived cells increases atherosclerosis in low-density lipoprotein receptor-\/- mice","volume":"31","author":"Thatcher","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"20","key":"10.1016\/j.redox.2023.103004_bib62","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJM199305203282008","article-title":"Pathogenetic mechanisms of septic shock","volume":"328","author":"Parrillo","year":"1993","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.redox.2023.103004_bib63","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/10799893.2023.2204960","article-title":"Sepsis modulates aortic AT1 and P(2)Y(6) receptors to produce vascular hyporeactivity in mice","volume":"43","author":"Jagadeesh","year":"2023","journal-title":"Journal of receptor and signal transduction research"},{"issue":"1","key":"10.1016\/j.redox.2023.103004_bib64","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1476-5381.1993.tb13789.x","article-title":"Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock","volume":"110","author":"Thiemermann","year":"1993","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.redox.2023.103004_bib65","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1161\/01.HYP.38.2.177","article-title":"Downregulation of angiotensin II type 1 receptors during sepsis","volume":"38","author":"Bucher","year":"2001","journal-title":"Hypertension (Dallas, Tex. : 1979)"},{"issue":"5","key":"10.1016\/j.redox.2023.103004_bib66","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s13054-014-0534-9","article-title":"Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study","volume":"18","author":"Chawla","year":"2014","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.redox.2023.103004_bib67","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40256-018-0297-9","article-title":"FDA approval of angiotensin II for the treatment of hypotension in adults with distributive shock","volume":"19","author":"Senatore","year":"2019","journal-title":"Am. J. Cardiovasc. Drugs : drugs, devices, and other interventions"},{"issue":"5","key":"10.1016\/j.redox.2023.103004_bib68","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.redox.2023.103004_bib69","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0024-3205(89)90601-2","article-title":"Changes in activity of the renin-angiotensin system of the rat by induction of acute inflammation","volume":"44","author":"Ohtani","year":"1989","journal-title":"Life Sci."},{"key":"10.1016\/j.redox.2023.103004_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105916","article-title":"Dysregulation of the renin-angiotensin system in septic shock: mechanistic insights and application of angiotensin II in clinical management","volume":"174","author":"Senatore","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.redox.2023.103004_bib71","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1006\/bbrc.1999.1226","article-title":"Transcriptional suppression of rat angiotensin AT1a receptor gene expression by interferon-gamma in vascular smooth muscle cells","volume":"262","author":"Ikeda","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.redox.2023.103004_bib72","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.cmet.2018.04.002","article-title":"FGF21 prevents angiotensin II-induced hypertension and vascular dysfunction by activation of ACE2\/angiotensin-(1-7) Axis in mice","volume":"27","author":"Pan","year":"2018","journal-title":"Cell Metabol."},{"issue":"6","key":"10.1016\/j.redox.2023.103004_bib73","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1253\/circj.CJ-14-1179","article-title":"Downregulation of the vascular renin-angiotensin system by aerobic training - focus on the balance between vasoconstrictor and vasodilator axes","volume":"79","author":"Silva","year":"2015","journal-title":"Circ. J. : official journal of the Japanese Circulation Society"},{"key":"10.1016\/j.redox.2023.103004_bib74","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3389\/fmed.2018.00365","article-title":"Tonin overexpression in mice diminishes sympathetic autonomic modulation and alters angiotensin type 1 receptor response","volume":"5","author":"Jara","year":"2018","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.redox.2023.103004_bib75","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/HYPERTENSIONAHA.112.203679","article-title":"Lack of specificity of commercial antibodies leads to misidentification of angiotensin type 1 receptor protein","volume":"61","author":"Herrera","year":"2013","journal-title":"Hypertension (Dallas, Tex. : 1979)"},{"issue":"8","key":"10.1016\/j.redox.2023.103004_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183278","article-title":"Validation of commercial Mas receptor antibodies for utilization in Western Blotting, immunofluorescence and immunohistochemistry studies","volume":"12","author":"Burghi","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.redox.2023.103004_bib77","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s10571-012-9862-y","article-title":"Six commercially available angiotensin II AT1 receptor antibodies are non-specific","volume":"32","author":"Benicky","year":"2012","journal-title":"Cell. Mol. Neurobiol."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231723004056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231723004056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T07:46:25Z","timestamp":1729496785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231723004056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":77,"alternative-id":["S2213231723004056"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2023.103004","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myeloid ACE2 protects against septic hypotension and vascular dysfunction through Ang-(1\u20137)-Mas-mediated macrophage polarization","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2023.103004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103004"}}